These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 326636)

  • 41. Editorial: Lysozyme.
    Osserman EF
    N Engl J Med; 1975 Feb; 292(8):424-5. PubMed ID: 1110730
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum lysozyme activity in inflammatory bowel disease.
    Levy N; Gibson RG; Mihas AA; Hirschowitz BI
    South Med J; 1978 Sep; 71(9):1109-11. PubMed ID: 684504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolyl hydroxylase activity in serum and rectal mucosa in inflammatory bowel disease.
    Farthing MF; Dick AP; Heslop G; Levene CI
    Gut; 1978 Aug; 19(8):743-7. PubMed ID: 210089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications.
    Seldenrijk CA; Morson BC; Meuwissen SG; Schipper NW; Lindeman J; Meijer CJ
    Gut; 1991 Dec; 32(12):1514-20. PubMed ID: 1773958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new approach using tissue alkaline phosphatase histochemistry to identify Crohn's disease.
    Torres MI; Lorite P; López-Casado MA; Ríos A
    Pathol Res Pract; 2007; 203(6):485-7. PubMed ID: 17498884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
    Boughton-Smith NK; Evans SM; Hawkey CJ; Cole AT; Balsitis M; Whittle BJ; Moncada S
    Lancet; 1993 Aug; 342(8867):338-40. PubMed ID: 7687730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L; Kuiper I; van Duijn W; Marklund SL; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.
    Cappello M; Keshav S; Prince C; Jewell DP; Gordon S
    Gut; 1992 Sep; 33(9):1214-9. PubMed ID: 1427374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. (2'-5')Oligoadenylate synthetase activity in intestinal mononuclear and epithelial cells of inflammatory bowel disease patients.
    Rachmilewitz D; Stalnikowicz R; Karmeli F; Youngman K; Fiocchi C
    Scand J Gastroenterol; 1988 Oct; 23(8):941-7. PubMed ID: 3201131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn's disease.
    Arvanitakis C
    Digestion; 1979; 19(4):259-66. PubMed ID: 478207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis.
    Allan ES; Winter S; Light AM; Allan A
    Gut; 1996 Jun; 38(6):886-93. PubMed ID: 8984028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of endotoxemia in ulcerative colitis and Crohn's disease. II. Experimental study.
    Aoki K
    Acta Med Okayama; 1978 Jul; 32(3):207-16. PubMed ID: 151486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lysozyme in plasma and neutrophilic granulocytes in ulcerative colitis and Crohn's disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Scand J Gastroenterol; 1977; 12(2):135-40. PubMed ID: 847381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease.
    Shannon VR; Stenson WF; Holtzman MJ
    Am J Physiol; 1993 Jan; 264(1 Pt 1):G104-11. PubMed ID: 7679252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diagnostic value of serum lysozyme activity in inflammatory bowel disease.
    Ayulo JA; Chen CC; Pelot D; Berk JE
    Am J Gastroenterol; 1977 Jul; 68(1):71-6. PubMed ID: 910787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations.
    O'Morain C; Smethurst P; Levi AJ; Peters TJ
    Gut; 1984 May; 25(5):455-9. PubMed ID: 6714788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study of endotoxemia in ulcerative colitis and Crohn's disease. I. Clinical study.
    Aoki K
    Acta Med Okayama; 1978 Jun; 32(2):147-58. PubMed ID: 150200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.